Experts from Canada's Global Nexus for Pandemics and Biological Threats and the Swedish university will work together to find research solutions to COVID-19 and to train future scientists and health professionals.
A study out of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University has resulted in the discovery of a promising new antimalarial compound.
The Lung Health Foundation and Canada’s Global Nexus for Pandemics and Biological Threats have partnered to provide Canadians with evidence-based, timely information on COVID-19 vaccine efficacy, infectious respiratory diseases and other public health measures put in place to manage risk and improve peoples’ health.
McMaster logo
McMaster logo
